BNET Industries

Able Laboratories Inc.

(ABRXQ) is in the Pharma Industry

Last Fiscal Year Sales:$103.1M
  • Public
  • US
Dow Jones Description

Able Laboratories, Inc. was a developer and manufacturer of generic pharmaceutical products in tablet, capsule, liquid and suppository dosage forms. In May 2005, Able suspended manufacturing and distribution of its entire product line. The company currently is not generating income or revenue, because of its suspension of manufacturing operations and product recalls. The company has filed a petition to reorganize under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of New Jersey, Trenton Division on July 18, 2005.

Vice President, Compliance & Regulatory Affairs
Iva Klemick
Number of Employees 421
Contact Information

1 Able Dr

Cranbury, New Jersey 85123-3609

ablelabs.com

(908) 754-2253

NAICS Code Pharmaceutical Preparation Manufacturing: 325412

News & Analysis

able laboratories inc. - All News and Analysis

Decision Makers

Name (plus bio) Position
Iva Klemick Vice President, Compliance & Regulatory Affairs

Iva Klemick as Vice President, Compliance & Regulatory Affairs, joined the Company in 1999 bringing over 25 years of experience in all areas of pharmaceutical operations including manufacturing, materials management, quality assurance, quality control and regulatory affairs. Prior to joining Able, she held Corporate Director positions in Planning, Material Management and QA/QC at Zenith Laboratories for over eight years. In her current position as Vice President, Compliance, Ms. Klemick is responsible for the management of ANDA filings and communications with all regulatory agencies.

Organization Position Status
Able Laboratories, Inc. Vice President, Compliance & Regulatory Affairs Current
Able Laboratories, Inc. Director, Regulatory Affairs Former
Able, LLC Former